RxDoctor Payments Data

Karissa Miller, PA

Physician Assistant · Indianapolis, INNPI 1023532108

Payments from drug & device makers

$3,296in general payments, 2019–2025

Across 87 payments — averaging $37.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$772
  • Boston Scientific$685
  • Abbott$426
  • Pfizer$186
  • Biotronik Inc.$172
  • Novo Nordisk$172
  • plus $884 from 18 others

What the payments were for

  • Food & beverage$3,27899%
  • Education$181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,296 in reported general payments places this provider in the 90th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana

Medicare billing

Part B allowed, 2024
$24,346
Medicare patients
223
Services billed
441

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban461$411,004
XareltoRivaroxaban42$44,201
Quinidine Sulfate12$20,628
Dofetilide83$9,155
Metoprolol Succinate558$6,615
Diltiazem 12hr ErDiltiazem Hcl15$2,866
Amiodarone Hcl198$2,823
SotalolSotalol Hcl71$1,587
Diltiazem 24hr Er (Cd)Diltiazem Hcl52$1,340
Potassium Chloride43$745
Flecainide Acetate25$582
Diltiazem 24hr Er (Xr)Diltiazem Hcl21$572
Dilt-XrDiltiazem Hcl13$515
Torsemide28$428
Amlodipine Besylate35$260

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$186$411,004461 claims
Johnson & JohnsonXarelto$26$44,20142 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,955 physician assistant providers in Indiana.

Other physician assistant in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →